Evidence map›Paper›PMID 38540165›Full record

ArticleBiomedicines2024

Computational and Experimental Approaches Exploring the Role of Hesperetin in Improving Autophagy in Rat Diabetic Retinopathy.

Reem Alshaman, Eman Kolieb, Rehab M El-Sayed, Sahar Galal Gouda, Abdullah Alattar, Sawsan A Zaitone, Asmaa K K Abdelmaogood, Lamiaa M Elabbasy, Amira H Eltrawy, Fai Yahya Sayd and 5 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Reem AlshamanDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk 47512, Saudi Arabia.
Eman KoliebPhysiology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.ORCID 0000-0001-6251-8516
Rehab M El-SayedDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University, El-Arish, North Sinai 45511, Egypt.
Sahar Galal GoudaDepartment of Histology and Cell Biology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
Abdullah AlattarDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk 47512, Saudi Arabia.ORCID 0000-0003-4909-7723
Sawsan A ZaitoneDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.ORCID 0000-0002-9688-7683
Asmaa K K AbdelmaogoodDepartment of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
Lamiaa M ElabbasyDepartment of Medical Biochemistry & Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
Amira H EltrawyDepartment of Anatomy, Faculty of Medicine, University of Tabuk, Tabuk 47512, Saudi Arabia.ORCID 0000-0003-1165-2891
Fai Yahya SaydPharmD Program, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia.
Hatem I MokhtarDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Sinai University-Kantara Branch, Ismailia 41636, Egypt.ORCID 0000-0002-9337-1809
Esam Ghanem Abu El WafaDepartment of Ophthalmology, Al-Azher Asyut Faculty of Medicine for Men, Asyut 71524, Egypt.
Esam Sayed AhmedDepartment of Ophthalmology, Al-Azher Asyut Faculty of Medicine for Men, Asyut 71524, Egypt.
Dong LiangDepartment of Pharmaceutical & Environmental Health Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA.ORCID 0000-0001-6632-8066
Dina A AliClinical Pharmacology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
Suez Canal University · EGUniversity of Tabuk · SAAl-Azhar University · EGSinai University · EGAlfaisal University · SATexas Southern University · US

Funding

The deanship of scientific research at the University of Tabuk, Saudi Arabia S-1443-0221
6 · The paper itself

Abstract

Diabetic retinopathy (DR) is a debilitating diabetic disorder of the retinal microvasculature and the main cause of avoidable blindness in old people. Hesperetin is a plant flavanone largely abundant in citrus species with neuroprotective properties in animal models. This study aimed to explore the neuroprotective and autophagy-enhancing effect of hesperetin in rats with DR. Twenty-four male rats were utilized and allocated to groups: (i) the vehicle group, (ii) DR group and (iii-iv) the DR + hesperetin (50 and 100 mg/kg) groups. Treatment with hesperetin continued for 6 weeks. After the rats were euthanized, their eyes were dissected to detect the biochemical and histological changes in the retinas. Quantification of autophagy markers, beclin 1/LC3/p62, and inflammation markers was performed. Histopathologic changes were investigated after staining with hematoxylin and eosin and periodic acid-Schiff (PAS). Results demonstrated that hesperetin decreased the PAS staining in diabetic rats and attenuated histopathological changes and restored retinal organization and thickness of layers in hematoxylin and eosin staining. Moreover, hesperetin reduced the level of mRNA expression for

Indexed as

autophagybeclin 1computational approachdiabetic retinopathyhesperetinrat

Identifiers

PMID38540165
PMCPMC10968489
OpenAlexW4392386553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.